Clindamycin/resin complexation has shown to be an efficient method to mask the taste of clindamycin and was developed into a suspension formulation that can be used in pediatrics.

No abstract

No abstract

This study presents potential proof for using FDFs as a replacement therapy of epinephrine injections for pediatrics.

The clindamycin stable complex with IER (Amberlite IRP69) has the potential for further development as a compatible pediatric liquid formulation (suspension) or a fast disintegrating tablet.

The global state of antibiotic resistance highlights the necessity for new drugs that can treat a wide range of microbial infections.